Experimental and Molecular Pathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.1 | Q1 | 86.7% | 1.109 | Q1 | 86.5% |
| 2024 | 3.7 | Q1 | 85.6% | 0.803 | Q1 | 78.0% |
| 2023 | 2.8 | Q2 | 65.4% | 0.726 | Q1 | 76.7% |
| 2022 | 3.6 | Q2 | 71.4% | 0.818 | Q1 | 81.2% |
| 2021 | 4.4 | Q2 | 72.4% | 0.703 | Q2 | 77.6% |
| 2020 | — | — | 0.791 | Q2 | 79.5% | |
| 2019 | — | — | 0.813 | Q1 | 80.8% | |
| 2018 | — | — | 0.821 | Q2 | 79.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0014-4800
ISSN
1096-0945
region
Northern America
coverage
1962-1995, 1997-2026